Orexigen Therapeutics (OREX) Posts Narrower than Expected Q4 Loss
Tweet Send to a FriendGet Alerts OREX Hot Sheet
Price: $6.04 -0.17%
Revenue Growth %: 0.0%
Financial Fact:
Interest income: 31K
Today's EPS Names:
LBIX, ESEA, ISS, More
Revenue Growth %: 0.0%
Financial Fact:
Interest income: 31K
Today's EPS Names:
LBIX, ESEA, ISS, More
Trade OREX Now!
Orexigen Therapeutics (NASDAQ: OREX) reported Q4 EPS of ($0.24), $0.05 better than the analyst estimate of ($0.29).
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Notable Winners and Losers from Q1 Earnings Season: (YRCW) (TSLA) (AVEO) (CRMB)
- Orexigen Therapeutics to Present at the UBS Global Healthcare Conference
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
